These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18613746)

  • 1. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
    Cobelens FG; Heldal E; Kimerling ME; Mitnick CD; Podewils LJ; Ramachandran R; Rieder HL; Weyer K; Zignol M;
    PLoS Med; 2008 Jul; 5(7):e150. PubMed ID: 18613746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.
    Chakaya JM; Marais B; du Cros P; Ntoumi F; Mfinanga S; Kapata N; Hasnain SE; Nathavitharana R; Zumla A
    Lancet Respir Med; 2020 Apr; 8(4):334-335. PubMed ID: 32113573
    [No Abstract]   [Full Text] [Related]  

  • 3. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress towards achieving global tuberculosis control: so near, yet so far.
    Zumla A; Davies PD
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703
    [No Abstract]   [Full Text] [Related]  

  • 5. [Managing multidrug-resistant tuberculosis].
    Antoun F; Véziris N
    Rev Mal Respir; 2011 Oct; 28(8):956-7. PubMed ID: 22099400
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug-resistant tuberculosis--can the tide be turned?
    Zumla A; Grange JM
    Lancet Infect Dis; 2001 Oct; 1(3):199-202. PubMed ID: 11871496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis.
    Byrne AL; Fox GJ; Marais BJ
    Future Microbiol; 2018 Apr; 13():577-588. PubMed ID: 29521120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment.
    Hwang TJ; Keshavjee S
    PLoS Med; 2014 Sep; 11(9):e1001738. PubMed ID: 25268235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO strategies for the management of drug-resistant tuberculosis.
    Rendon A; Centis R; D'Ambrosio L; Migliori GB
    Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cellular technologies in therapy for chronic multidrug-resistant pulmonary tuberculosis].
    Erokhin VV; Tsyb AF; Chukanov VI; Vasil'eva IA; Bagdasarian TR; Konopliannikov AG; Kolesnikova AI; Danilenko AA; Lepekhina LA; Kal'sina SSh
    Probl Tuberk Bolezn Legk; 2006; (8):3-5. PubMed ID: 17002048
    [No Abstract]   [Full Text] [Related]  

  • 11. Stop TB Partnership has provided treatments for 10 million people in 6 years.
    Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093
    [No Abstract]   [Full Text] [Related]  

  • 12. [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis].
    Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Oct; 37(10):733-6. PubMed ID: 25537407
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing the game for multidrug-resistant tuberculosis.
    Ghanashyam B
    Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom.
    Williams B; Ramroop S; Shah P; Anderson L; Das S; Riddell A; Liebeschuetz S; Bernatoniene J; Shingadia D; Kampmann B
    Pediatr Infect Dis J; 2013 Aug; 32(8):926-7. PubMed ID: 23856715
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 16. Getting health services to three million people with TB.
    Pérez H
    J Int AIDS Soc; 2014; 17(1):19079. PubMed ID: 24666595
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-resistance--a challenge for tuberculosis control in the European Union and European Economic Area.
    van der Werf MJ; Sprenger M
    Euro Surveill; 2014 Mar; 19(11):. PubMed ID: 24679718
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.
    van der Werf MJ; Sandgren A; Manissero D
    Int J Tuberc Lung Dis; 2012; 16(3):426. PubMed ID: 22640458
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug development for tuberculosis: the missing ingredient.
    Reichman LB; Fanning A
    Lancet; 2001 Jan; 357(9251):236. PubMed ID: 11213133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.